Abstract
Objective
To improve the production of A40926, a combined strategy of constructing the engineered strain and optimizing the medium was implemented.
Results
The engineered strain lcu1 with the genetic features of dbv23 deletion and dbv3-dbv20 coexpression increased by 30.6% in the production of A40926, compared to the original strain. In addition, a combined medium called M9 was designed to be further optimized by the central composite design method. The optimized M9 medium was verified to significantly improve the A40926 yield from 257 to 332 mg l−1.
Conclusions
The engineered strain lcu1 could significantly promote A40926 production in the optimized M9 medium, which indicated that the polygenic genetic manipulation and the media optimization played an equally important role in increasing the A40926 yield.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alduina R, Lo Piccolo L, D’Alia D, Ferraro C, Gunnarsson N, Donadio S, Puglia AM (2007) Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926. J Bacteriol 189:8120–8129. https://doi.org/10.1128/JB.01247-07
Alduina R, Sosio M, Donadio S (2018) Complex regulatory networks governing production of the glycopeptide A40926. Antibiotics. https://doi.org/10.3390/antibiotics7020030
Alduina R, Tocchetti A, Costa S, Ferraro C, Cancemi P, Sosio M, Donadio S (2020) A two-component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance. Sci Rep 10:6200. https://doi.org/10.1038/s41598-020-63257-4
Beltrametti F, Jovetic S, Feroggio M, Gastaldo L, Selva E, Marinelli F (2004) Valine influences production and complex composition of glycopeptide antibiotic A40926 in fermentations of Nonomuraea sp. ATCC 39727. J Antibiot 57:37–44. https://doi.org/10.7164/antibiotics.57.37
Buttner M et al (2000) Practical streptomyces genetics. John Innes Foundation, Norwich
Chen CFZH, Zhang CQ, Hu HF (2015) Breeding the high-producer of A40926 and improving its fermentation technology Chinese. J Antibiot 40:28–32. https://doi.org/10.3969/j.issn.1001-8689.2015.01.005
Chen M, Xu T, Zhang G, Zhao J, Gao Z, Zhang C (2016) High-yield production of lipoglycopeptide antibiotic A40926 using a mutant strain Nonomuraea sp. DP-13 in optimized medium. Prep Biochem Biotechnol 46:171–175. https://doi.org/10.1080/10826068.2015.1015561
Dong H, Yue X, Yan B, Gao W, Wang S, Li Y (2020) Improved A40926 production from Nonomuraea gerenzanensis using the promoter engineering and the co-expression of crucial genes. J Biotechnol 324:28–33. https://doi.org/10.1016/j.jbiotec.2020.09.017
Gunnarsson N, Bruheim P, Nielsen J (2003) Production of the glycopeptide antibiotic A40926 by Nonomuraea sp. ATCC 39727: influence of medium composition in batch fermentation. J Ind Microbiol Biotechnol 30:150–156. https://doi.org/10.1007/s10295-003-0024-6
Ho JY, Huang YT, Wu CJ, Li YS, Tsai MD, Li TL (2006) Glycopeptide biosynthesis: Dbv21/Orf2 from dbv/tcp gene clusters are N-Ac-Glm teicoplanin pseudoaglycone deacetylases and Orf15 from cep gene cluster is a Glc-1-P thymidyltransferase. J Am Chem Soc 128:13694–13695. https://doi.org/10.1021/ja0644834
Huang LLSX, Chen SX (2012) Optimization of fermentation medium and mutation breeding a glycopeptide antibiotic A40926 B producing strain. Chin J Pharm 43:256–259. https://doi.org/10.3969/j.issn.1001-8255.2012.04.006
Jovetic S, Feroggio M, Marinelli F, Lancini G (2008) Factors influencing cell fatty acid composition and A40926 antibiotic complex production in Nonomuraea sp. ATCC 39727. J Ind Microbiol Biotechnol 35:1131–1138. https://doi.org/10.1007/s10295-008-0392-z
Kruger RG, Lu W, Oberthur M, Tao J, Kahne D, Walsh CT (2005) Tailoring of glycopeptide scaffolds by the acyltransferases from the teicoplanin and A-40,926 biosynthetic operons. Chem Biol 12:131–140. https://doi.org/10.1016/j.chembiol.2004.12.005
Liu YC et al (2011) Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds. Nat Chem Biol 7:304–309. https://doi.org/10.1038/nchembio.556
Liu ZYLJ, Zhu BF et al (2018) High-throughput screening for A40926 high producing strain. Chin J Pharm 49:316–321. https://doi.org/10.16522/j.cnki.cjph.2018.03.008
Lo Grasso L, Maffioli S, Sosio M, Bibb M, Puglia AM, Alduina R (2015) Two master switch regulators trigger A40926 biosynthesis in Nonomuraea sp. strain ATCC 39727. J Bacteriol 197:2536–2544. https://doi.org/10.1128/JB.00262-15
Marcone GL, Carrano L, Marinelli F, Beltrametti F (2010) Protoplast preparation and reversion to the normal filamentous growth in antibiotic-producing uncommon actinomycetes. J Antibiot 63:83–88. https://doi.org/10.1038/ja.2009.127
Marcone GL, Binda E, Carrano L, Bibb M, Marinelli F (2014) Relationship between glycopeptide production and resistance in the actinomycete Nonomuraea sp. ATCC 39727. Antimicrob Agents Chemother 58:5191–5201. https://doi.org/10.1128/AAC.02626-14
Marschall E, Cryle MJ, Tailhades J (2019) Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics. J Biol Chem 294:18769–18783. https://doi.org/10.1074/jbc.REV119.006349
Sosio M, Stinchi S, Beltrametti F, Lazzarini A, Donadio S (2003) The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by Nonomuraea species. Chem Biol 10:541–549. https://doi.org/10.1016/s1074-5521(03)00120-0
Sosio M, Canavesi A, Stinchi S, Donadio S (2010) Improved production of A40926 by Nonomuraea sp. through deletion of a pathway-specific acetyltransferase. Appl Microbiol Biotechnol 87:1633–1638. https://doi.org/10.1007/s00253-010-2579-2
Technikova-Dobrova Z et al (2004) Design of mineral medium for growth of Actinomadura sp. ATCC 39727, producer of the glycopeptide A40926: effects of calcium ions and nitrogen sources. Appl Microbiol Biotechnol 65:671–677. https://doi.org/10.1007/s00253-004-1626-2
Yan LHC, Zhu CY et al (2013) Breeding high-producer of glycopeptide antibiotic A40926. Chin J Pharm 44:143–145
Yim G, Thaker MN, Koteva K, Wright G (2014) Glycopeptide antibiotic biosynthesis. J Antibiot 67:31–41. https://doi.org/10.1038/ja.2013.117
Yue X, Xia T, Wang S, Dong H, Li Y (2020a) Highly efficient genome editing in N. gerenzanensis using an inducible CRISPR/Cas9-RecA system. Biotechnol Lett 42:1699–1706. https://doi.org/10.1007/s10529-020-02893-2
Yue X, Yan B, Wang S, Gao W, Zhang R, Dong H (2020b) Preparation of pH-responsive alginate-Chitosan microspheres for L-valine loading and their effects on the A40926 production. Curr Microbiol 77:1016–1023. https://doi.org/10.1007/s00284-020-01894-8
Yushchuk O et al (2021) Genomic-led discovery of a novel glycopeptide antibiotic by Nonomuraea coxensis DSM 45129. ACS Chem Biol 16:915–928. https://doi.org/10.1021/acschembio.1c00170
Acknowledgements
This work was supported by the Natural Science Foundation of Shandong Province (Grant No. ZR2015CL001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yan, B., Gao, W., Tian, L. et al. Production enhancement of the glycopeptide antibiotic A40926 by an engineered Nonomuraea gerenzanensis strain. Biotechnol Lett 44, 259–269 (2022). https://doi.org/10.1007/s10529-021-03210-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-021-03210-1